- ►prsjournal.com RB Bhisitkul - British Medical Journal, 2006 - bjo.bmj.com Decades of research on vascular endothelial growth factor (VEGF) have reached
fruition with the recent development of intravitreal anti-VEGF treatments for
exudative age-related macular degeneration. VEGF is a critical regulator of ... Cited by 44 - Related articles - BL Direct - All 6 versions
PK Kaiser - American journal of ophthalmology, 2006 - Elsevier To provide an overview of angiogenesis and vascular endothelial growth factor
(VEGF) and discusses the development approach, safety, and efficacy results of
current and emerging anti-VEGF therapies for ocular diseases. Cited by 51 - Related articles - All 14 versions
PK Kaiser, DV Do - International Journal of Clinical Practice, 2007 - interscience.wiley.com Age-related macular degeneration (AMD) is the leading cause of adult blindness
among individuals aged 50 and older in the Western world, with the neovascular
form of AMD responsible for the most severe and rapid visual loss. Although ... Cited by 6 - Related articles - BL Direct - All 4 versions
DJ Pieramici, RL Avery - Expert Opin. Biol. Ther., 2006 - informahealthcare.com Vascular endothelial growth factor (VEGF)-A is a major regulator of angiogenesis
and vascular permeability implicated in the development of diseases involving
pathological angiogenesis and increased vascular permeability, such as ... Cited by 14 - Related articles - BL Direct - All 4 versions
MC Gillies - Archives of Ophthalmology, 2006 - archopht.highwire.org The emerging vascular endothelial growth factor (VEGF) antagonists appear so far
to represent a genuine breakthrough in the treatment of subretinal
neovascularisation. Pegaptanib sodium (Macugen; OSI Eyetech, Melville, NY) ... Cited by 19 - Related articles - BL Direct - All 3 versions
C Starita, M Patel, B Katz, A Adamis - Developments in Ophthalmology, 2007 - content.karger.com Abstract Both clinical and preclinical findings have implicated vascular
endothelial growth fac- tor (VEGF) in the pathophysiology of diabetic macular
edema (DME). VEGF is both a potent enhancer of vascular permeability and a ... Cited by 28 - Related articles - BL Direct - All 5 versions
- ►prsjournal.com PA QUIRAM, TS HASSAN, GA WILLIAMS - Retina, 2007 - journals.lww.com Skip Navigation Links Home > September 2007 - Volume 27 - Issue 7 > Treatment of
Naive Lesions in Neovascular Age-Related Macula... ... From Associated Retinal
Consultants, Beaumont Hospital, Royal Oak, Michigan. Cited by 10 - Related articles - BL Direct - All 4 versions
- ►prsjournal.com PU Dugel - International ophthalmology clinics, 2006 - journals.lww.com Neovascular age-related macular degeneration (AMD), a debilitating ocular
disease that can eventually cause visual loss, is the leading cause of blindness
among the elderly in the United States. An estimated 1.75 million people in ... Cited by 3 - Related articles - BL Direct - All 4 versions
H Quiroz-Mercado, O Ustariz-González, MA … - Seminars in Ophthalmology, 2007 - informahealthcare.com This retrospective report describes our 20 months'experience using intravitreal
injections of bevacizumab for the treatment of several retinal diseases. We
describe our experience after 1765 intravitreal injections of bevacizumab ... Cited by 14 - Related articles - BL Direct - All 6 versions
G Liew, P Mitchell, MC Gillies, TY Wong, PJ … - The New England journal of medicine, 2007 - nejm.highwire.org In the population-based Blue Mountains Eye Study, 4 conducted from 1992 through
1994 and involving 3654 adults over the age of 49 years, we observed 19 arterial
thromboembolic events (incident nonfatal stroke, nonfatal myocardial ... Cited by 36 - Related articles - All 4 versions
